IMDX Price / Book | Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. (IMDX) Price / Book

2025-06-30: Price/Book Ratio 78.71.
2025-03-31: Price/Book Ratio 8.56.
2024-09-30: Price/Book Ratio 3.93.
2024-06-30: Price/Book Ratio 1.74.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-12-31 to 2025-06-30
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2025-06-30	78.71
2025-03-31	8.56
2024-09-30	3.93
2024-06-30	1.74
2024-03-31	2.09
2023-12-31	1.01
2023-09-30	0.71
2023-06-30	0.87
2023-03-31	22.26
2022-12-31	1.11
2022-09-30	22.53
2022-06-30	25.65
2022-03-31	48.26
2021-12-31	61.38
2021-09-30	66.05
2021-06-30	100.99
2021-03-31	86.56
2020-12-31	98.67
2020-09-30	53.97
2020-06-30	64.85
2020-03-31	83.6
2019-12-31	83.22
2019-09-30	74.41
2019-06-30	77.25
2019-03-31	107.52
2018-12-31	327.88
2018-09-30	270.26
2018-06-30	293.57
2018-03-31	176.05
2017-12-31	664.33
2017-09-30	589.46
2017-06-30	544.44
2017-03-31	398.34
2016-12-31	410.86
2016-09-30	227.95
2016-06-30	405.35
2016-03-31	339.81
2015-12-31	304.68

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
BIOMERICA INC (BMRA)	United States	$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)	United States	$0.008B	-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)	United States	$0.006B
VOLITIONRX LTD (VNRX)		$0.003B	-0.64
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92